We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Podium Session 3: Oncology - Bladder, Kidney, Testes Sunday, June 30, 2024 • 13:20-14:20.
- Abstract
The article discusses the development and validation of PROGRxN-BCa, an artificial intelligence-based tool for predicting 5-year progression risk in non-muscle-invasive bladder cancer (NMIBC). It outperforms current prognostic tools, improves stratification of intermediate-risk patients, and demonstrates high accuracy in predicting time to progression, offering potential benefits for treatment decision-making and clinical trial enrollment.
- Subjects
CANADA; BRITISH Columbia; NON-muscle invasive bladder cancer; RISK assessment; KIDNEY tumors; LYMPH nodes; PREDICTION models; ARTIFICIAL intelligence; RADIOMICS; TUMOR markers; BODY fluid examination; SURGICAL stents; CONFERENCES &; conventions; RENAL cell carcinoma; TRANSURETHRAL resection of bladder; TESTIS tumors; NEPHROSTOMY; DISEASE risk factors
- Publication
Canadian Urological Association Journal, 2024, Vol 18, pS11
- ISSN
1911-6470
- Publication type
Article
- DOI
10.5489/cuaj.8822